The PodPAD project: a podiatry-led integrated pathway for people with peripheral arterial disease in the UK – a pilot study by Farndon, Lisa et al.
The PodPAD project: a podiatry-led integrated pathway for 
people with peripheral arterial disease in the UK – a pilot 
study
FARNDON, Lisa, STEPHENSON, John, BINNS-HALL, Oliver, KNIGHT, 
Kayleigh and FOWLER-DAVIS, Sally <http://orcid.org/0000-0002-3870-9272>
Available from Sheffield Hallam University Research Archive (SHURA) at:
http://shura.shu.ac.uk/21604/
This document is the author deposited version.  You are advised to consult the 
publisher's version if you wish to cite from it.
Published version
FARNDON, Lisa, STEPHENSON, John, BINNS-HALL, Oliver, KNIGHT, Kayleigh and 
FOWLER-DAVIS, Sally (2018). The PodPAD project: a podiatry-led integrated 
pathway for people with peripheral arterial disease in the UK – a pilot study. Journal 
of Foot and Ankle Research, 11, p. 26. 
Copyright and re-use policy
See http://shura.shu.ac.uk/information.html
Sheffield Hallam University Research Archive
http://shura.shu.ac.uk
RESEARCH Open Access
The PodPAD project: a podiatry-led
integrated pathway for people with
peripheral arterial disease in the
UK – a pilot study
Lisa Farndon1* , John Stephenson2, Oliver Binns-Hall1, Kayleigh Knight1 and Sally Fowler-Davis3
Abstract
Background: Peripheral arterial disease affects the lower limb and is associated with diabetes, high cholesterol,
smoking and obesity. It increases the risk of cardiovascular morbidity and mortality. It can be symptomatic causing
intermittent claudication, but often there are few clinical signs. Podiatrists are able to detect the presence of
peripheral arterial disease as part of their lower limb assessment and are well placed to give advice on lifestyle
changes to help reduce disease progression. This is important to improve health outcomes and is offered as a
prevention/public health intervention.
Method: We describe the clinical and patient-centred outcomes of patients attending a podiatry-led integrated
care pathway in a multi-use clinic situated in a venue supported by the National Centre for Sports and Exercise
Medicine in the UK. At the baseline appointment, patients were given a full assessment where symptoms of
intermittent claudication using the Edinburgh Intermittent Claudication Questionnaire, foot pulses, Doppler
sounds, Ankle Brachial Pressure Indices, glycated haemoglobin (HbA1c) and cholesterol levels, and smoking
status were recorded. A tailored treatment plan was devised, including referral to an exercise referral service,
smoking cessation programmes (if applicable) and each participant was also seen by a dietician for nutritional
advice. Participants were followed up at 3 and 6 months to assess any improvement in vascular status and
with each completing the EQ-5D quality of life questionnaire and a simple satisfaction questionnaire at the
end of the study. As this was a complex intervention a pilot study design was adopted to evaluate if the
method and outcomes were suitable and acceptable to participants the results of which will then inform
the design of a larger study.
Results: Data was collected on 21 individuals; 15 men (71.4%) and 6 women (28.6%) across the 6-month study period.
Eleven participants were referred onto the exercise referral service; 16 participants saw the dietician for nutritional advice
at baseline and had one-to-one or telephone follow-up at 3 months. Five out of 14 participants had reduced scores from
baseline of intermittent claudication during the study period. No evidence for substantive changes in Doppler sounds or
ABPI measurements was revealed. Quality of life scores with the EQ-5D improved in 15 participants; this was statistically
significant (p = 0.007) with 14 participants who completed the simple satisfaction questionnaire expressing a positive view
of the programme. Of the four people who were smokers, two stopped smoking cigarettes and moved to e-cigarettes as
part of smoking cessation advice.
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Conclusion: As this was a pilot study the sample size was low, but some statistically significant improvements with some
measures were observed over the 6-month study. Podiatrists are able to provide a comprehensive vascular assessment of
the lower limb and accompanying tailored advice on lifestyle changes including smoking cessation and exercise.
Locating clinics in National Centres for Sports and Exercise Medicine enables easy access to exercise facilities to
encourage the adoption of increased activity levels, though the long term sustainability of exercise programmes
still requires evaluation.
This study was reviewed and approved by London Brent Ethics Committee IRAS ID 204611 and received research
governance approval from the sponsor, Sheffield Teaching Hospitals NHS Foundation Trust Research and Innovation
Office STH19410.
Keywords: Peripheral arterial disease, Activity, Intermittent claudication, Quality of life, Integrated pathway, Podiatry led,
National Centres for sports and exercise medicine, Public health
Background
Peripheral Arterial Disease (PAD) is a long-term condition
characterised by atherosclerotic obstruction of the lower
extremity arteries [1], and is a marker of patients who are
at increased risk of cardiovascular events, including myo-
cardial infarction and stroke. The incidence in the
over-60s is approximately 20%; increasing with age and
other factors, including: smoking, diabetes and existing
coronary arterial disease [2]. Globally, 202 million people
had PAD in 2010, with a 28% increase in low and moder-
ate income countries and 13% in high-income countries
in the preceding decade [3]. In the lower limb, PAD may
be symptomatic with intermittent claudication or asymp-
tomatic and can lead to, foot ulceration and critical limb
ischaemia; all of which can result in amputation. Heavy
smokers are four times more likely to develop intermittent
claudication compared to non-smokers [4]. Intermittent
claudication is also associated with reduced quality of life
and depression [5].
As clinicians of the lower limb, podiatrists are able to
assess patients for signs of PAD; offering treatment,
surveillance, advice and follow on referral to the vascular
surgery team if needed. The clinical evidence base sug-
gests that this intervention (foot care and advice on diet,
exercise and smoking) is highly effective at reducing the
progression into acute care and can reduce the incidence
of amputation by 60% [6]. Strict pharmacological man-
agement of cardiovascular risks specifically in people
with diabetes and foot ulceration has been shown to
reduce mortality rates [7]. It is recommended that all
commissioners and providers should have a clear path-
way for patients suspected of PAD in the UK [6].
National Institute for Health and Care Excellence
(NICE) guidelines [2] recommend that people who are
at risk or have symptoms of PAD, including those who
have diabetes and non-healing wounds, or have unex-
plained leg pain should be given a full assessment. This
should involve documenting the presence and severity of
symptoms of intermittent claudication and rest pain,
examining the feet and legs for evidence of any lesions/
ulcerations, examining pulses in the lower limb by
palpation and Doppler ultrasound and calculate the
ankle brachial pressure index (ABPI). Diagnosis is con-
firmed with reduced, absent or monophasic pulse
sounds with a Doppler and an ABPI < 0.9.
This study was funded to support allied health profes-
sions in public health in the UK [6] and to support
podiatry assessment and treatment to prevent mortality
and amputation [7]. Significant gains in wellbeing for
individual patients and cost savings from preventing
interventions can be achieved from improved population
level health outcomes [5]. These clinical interventions
align to the evidence and to the implementation of pre-
vention strategies in podiatry services [9].
Treatment
Early identification of both asymptomatic and symp-
tomatic PAD allows for early intervention: slowing
disease progression and decreasing the risk of lower
limb amputation and cardiovascular morbidity and
mortality [8]. The overall aim is to sustain or improve
mobility and quality of life. Key areas to the manage-
ment of symptoms include: smoking cessation, weight
management and increased activity. Regular exercise
can reduce cardiovascular mortality by 50% [9] and is
an effective treatment for PAD [10, 11]. Other treat-
ments include lipid modification and statin therapy,
the prevention, management of diabetes (if applic-
able), management of high blood pressure (if applic-
able) and antiplatelet therapy (if required). If
conservative treatments are not effective patients can
develop more severe PAD where a surgical interven-
tion in the form of angioplasty or bypass graft may
be required [12]. The aim of this study was to inves-
tigate the feasibility of a podiatry-led integrated care
pathway in the UK, utilising advice on diet, activity
and smoking cessation for people with PAD and
measuring the clinical and patient centred outcomes.
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Methods
The study was located at a UK National Centre for
Sports and Exercise Medicine, in which health care
clinics are situated in existing leisure/sports facilities.
This allowed easy access to gym facilities for partici-
pants, if they agreed to this as part of their activity
programme. Outcomes considered to be favourable
were: improvement in symptoms of PAD (reduction in
intermittent claudication pain if present), improved
ABPI readings, increase in number of pedal pulses pal-
pated or a change in Doppler sounds from monophasic
to bi or tri-phasic, decrease in cholesterol and HbA1c
levels (if applicable) and the success of any smoking ces-
sation and activity programmes. Quality of life and pa-
tient satisfaction with the programme was also assessed.
Patients were excluded if they were unable to give in-
formed consent due to lack of mental capacity and if
they were unable to participate in increased activity due
to other co-morbidities.
Inclusion criteria: Patients who were on the podiatry
service PAD caseload were purposively sampled to take
part in this pilot study. Anyone wishing to take part was
given an information sheet, and an appointment was
arranged for a baseline assessment.
Exclusion criteria: housebound patients, patients
who had poor mobility and would be unable to take
part in any activity programme and patients who were
not able to give informed consent. At baseline med-
ical history was recorded, with any symptoms associ-
ated with PAD assessed using the Edinburgh
Intermittent Claudication Questionnaire [13]; and ab-
sence or presence of lower limb pulses on palpation,
tri-, bi- or mono-phasic lower limb pulse sounds with
a Doppler and ABPIs assessed with a Dopplex Ability
System®. The EQ-5D questionnaire was given to each
participant to complete to assess quality of life [13].
Clinical measurements were taken by experienced
research podiatrists with training in vascular assess-
ment. Based on this assessment, the research podia-
trists tailored a treatment plan, which included advice
about smoking cessation and local support services to
support stopping smoking and weight loss (if applic-
able), recommendation to the physical activity referral
scheme and participants were also given the oppor-
tunity to meet with a dietician who was present in an
adjoining clinic room to get advice about nutrition
and weight loss (again, if applicable).
Data collection
Several outcome measures were recorded on participants
at three time points: baseline; 3 months and 6 months.
Changes from baseline to 6 months were considered to be
the primary comparisons of interest.
Peripheral arterial disease
Symptoms of PAD were assessed by means of the
Edinburgh Intermittent Claudication Questionnaire
(EICQ). This questionnaire comprised 5 questions, all of
which could be answered with a “yes” or “no”. The first
question was the following screening question:
Do you get pain or discomfort in your legs when
you walk?
If participants answered “yes” to this question, they were
then requested to answer the following further 4
questions:
1. Does the pain ever begin when you are standing
still or sitting?
2. Do you get this pain if you walk uphill or when you
hurry?
3. Do you get this pain when you walk at an ordinary
pace on the level?
4. Does the pain disappear when you rest for less than
10 min?
The respective responses Yes, No, Yes, Yes, Yes were
taken as likely indicators of the presence of intermittent
claudication (IC). A score was derived for each partici-
pant with 1 point being awarded for each instance of a
response corresponding to a likely indicator of the pres-
ence of IC due to PAD (excluding presence of IC due to
causes other than PAD, such as spinal stenosis). Hence
scores could range from 0 (no IC; given to those who
answered “no” to the first question) to 5 (highly likely
presence of IC) per participant.
Pulse measurements
Left and right posterior tibial, anterior tibial, dorsalis
pedis and popliteal pulse measurements were obtained
from participants at each time point, amounting to 8
measurements in total per visit. A score was derived
for each participant, with 1 point being awarded for
each palpable pulse reading; scores could range from
0 (indicating no pulses were palpable) to 8 (all pulses
were palpable).
Doppler readings
Doppler sound readings were also taken of left and right
lower limb pulses from all participants at each time
point, amounting to 8 measurements in total. Sound
readings were classified as triphasic, biphasic or mono-
phasic; with triphasic considered to be the optimum
status.
HbA1c and cholesterol
Glycated haemoglobin (HbA1c) and cholesterol readings
(if applicable) were recorded from the electronic patient
Farndon et al. Journal of Foot and Ankle Research  (2018) 11:26 Page 3 of 11
record as near to each appointment time point as pos-
sible if these were available.
ABPI readings
Left and right ABPI readings were obtained from each
participant at each time point using the Dopplex ability.
Overall values were calculated for each participant for
each time point. Values < 0.9 are an indication of PAD,
with lower values indicating greater severity of disease.
Quality of life and patient satisfaction
The EQ-5D was administered to participants at each
appointment. This instrument consists of 5 questions,
relating to: mobility; self-care; usual activities; pain/dis-
comfort; and anxiety/depression. All questions were
5-point Likert-style items, with a score of 1 representing
no problems, and 5 representing extreme problems.
Additionally, participants rated their overall quality of
life on a 10-point visual analogue scale (VAS), with
higher scores representing higher quality of life. A sim-
ple satisfaction questionnaire consisting of 5 questions
with a free text section at the end was administered at
the 6 month appointment.
Statistical analysis
The sample was summarised descriptively; with gender,
smoking status and co-morbidities reported for all
patients. Additional qualitative information for partici-
pant satisfaction was also collected and summarised.
All outcome measures were summarised at each of the
three measured time points. Patterns of missingness and
the effect of missing data values were assessed where
appropriate. Paired samples t-tests were conducted on the
full EICQ scores, pulse measurements, ABPI measure-
ments, HbA1c levels and cholesterol levels and overall
quality of life scores to assess the significance of the change
in these measures from baseline to the 6-month
post-baseline assessment. Effect sizes and associated 95%
confidence intervals were also reported for these measures.
Further analysis was conducted on the EICQ screening
question to investigate any trends over time in the propor-
tion of participants with IC. Similar procedures were con-
ducted on the proportions of participants recording ABPI
measurements in either or both legs below a critical value.
Overall trends in the proportions of participants with tri-,
bi- and monophasic Doppler readings were also investi-
gated. Individual EQ-5D item scores were analysed using
multivariate methods.
Ethical permissions
Ethical and research governance approval was given
prior to commencement of the project and Patient and
Public Involvement (PPI) was sought from a Citizens
Reference Group and a local hospital panel. Both gave
feedback on the study design and patient information
sheet.
Results
Data was collected on 21 individuals; 15 men (71.4%)
and 6 women (28.6%). At baseline, 4 participants (19.0%)
reported themselves to be smokers; 17 participants
(81.0%) were non-smokers, of these 9 were ex-smokers
and 8 had never smoked.
Participants also reported a number of co-morbidities
at baseline; nine (42.9%) had hypertension; 15 (71.4%)
had diabetes; 4 (19.0%) had hyperlipidaemia; 4 (19.0%)
had kidney disease; 3 (14.3%) had a previous stroke or
transient ischaemic attack; 4 (19.0%) had ischemic heart
disease (IHD) and 5 (23.8%) had a previous myocardial
infarction (MI).
Assessment of peripheral arterial disease
All 21 participants provided responses to the Edinburgh
Intermittent Claudication Questionnaire (EICQ) at the
baseline assessment, ranging from 0 to 5. The mean
baseline score was 2.62 (SD 1.80). At the 3-month
assessment, 16 participants provided responses, again
ranging from 0 to 5, and the mean score was 2.38 (SD
1.59). At the 6-month assessment, 14 participants
provided responses, again ranging from 0 to 5 and the
mean score was 2.36 (SD 1.78).
Fourteen participants provided data both at baseline
and at the final 6-month assessment. The EICQ score of
5 participants reduced over this time period; whilst the
EICQ score of 2 participants increased. The scores of
the remaining 7 participants was unchanged. A paired
samples t-test conducted on the respondents who pro-
vided data both at baseline and at 6 months found a
mean reduction of 0.643 points (SD 1.34). A 95% confi-
dence interval for the difference between baseline and
6-month data was given by (− 0.129, 1.41). The differ-
ence, though substantive, was not significant at the 5%
significance level (t13 = 1.80; p = 0.095) (Fig. 1).
There was no evidence that missing EICQ data was
not missing completely at random (MCAR) according to
Little’s MCAR test (χ2(3) = 4.41; p = 0.220).
Further analysis was conducted on the response to the
first question alone; which was taken as a likely indicator
of the presence of IC. At baseline, 12 participants
(57.1%) were assessed to have IC. Of these 11 had other
signs of PAD such as some absent pulses on palpation
and or monophasic Doppler sounds. Only 1 participant
had no other signs of PAD, so their pain may have been
neurological in origin. Eight participants completed their
3-month assessment, of which 7 (87.5% of those com-
pleting the 3-month assessment) were assessed to still
have IC. Nine participants completed their 6-month
assessment (one participant who missed their 3-month
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assessment returned for the 6-month assessment). Of
these, 6 were assessed to still have IC (66.7%) and 3 were
not.
Hence overall at 6 months, 6 participants out of 12
(50.0%) were assessed to have IC; with a net change of 2
patients moving from the group with IC to the group
without IC.
Of the 8 participants assessed not to have IC at base-
line, 5 completed their 3-month assessment. Four were
assessed to still not have IC; 1 participant was assessed
to have IC at 6 months.
Pulse measurements
All 21 participants provided pulse measurements at the
baseline assessment, with scores ranging from 0 to 8
(mean 5.33 (SD 2.67)). At the 3-month assessment, 15
participants provided responses, ranging from 2 to 8
(mean 6.07 (SD 2.05)). At the 6-month assessment, 14
participants provided responses, ranging from 1 to 8
(mean 6.69 (SD 2.02)).
Thirteen participants provided pulse readings both at
baseline and at the 6-month assessment. Of these, the
scores of 7 participants increased over this time period;
whilst scores of 2 participants reduced, with scores of 4
unchanged. A paired samples t-test conducted on the re-
spondents who provided data both at baseline and at
6 months found a mean increase of 0.769 points (SD 2.20).
A 95% confidence interval for the difference between the
two time points was given by (− 0.562, 2.10). The difference
was not significant at the 5% significance level (t12= 1.26;
p = 0.232) (Fig. 2).
Doppler sound readings
At baseline, participants recorded on average 3.52 mono-
phasic readings (SD 2.60); 4.38 biphasic readings (SD
2.50) and 0.10 triphasic readings (SD 0.30). At 3 months,
participants recorded on average 2.47 monophasic read-
ings (SD 2.45); 5.00 biphasic readings (SD 2.07) and 0.27
triphasic readings (SD 0.59). At 6 months, participants re-
corded on average 2.47 monophasic readings (SD 2.77);
5.07 biphasic readings (SD 2.69) and 0.27 triphasic read-
ings (SD 0.59).
Hence no clear trends in recordings were observed
over the three measured time points; however, the pro-
portion of triphasic readings increased slightly from
baseline to 3 months; with negligible further changes in
any proportions between 3 and 6 months.
ABPI readings
At baseline, ABPI data was obtained from 17 partici-
pants; of whom 6 (35.3%) had overall ABPI values below
0.90 in one or both legs (range from 0.56 to 1.45). The
mean value for all participants providing a reading at
this time point was 0.998 (SD 0.229) in the left leg and
0.947 (SD 0.220) in the right leg. At 3 months, data was
obtained from 9 participants, of whom 5 (55.6%) had
Fig. 1 EICQ scores at baseline and at 6 months, with 95% confidence intervals
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overall ABPI values below 0.90 in one or both legs
(range from 0.77 to 1.29). The mean value for all partici-
pants providing a reading at this time point was 0.948
(SD 0.210) in the left leg and 0.921 (SD 0.195) in the
right leg. At 6 months, data was obtained from 10 par-
ticipants; of which 4 (40.0%) had overall ABPI values
below 0.90 (range from 0.75 to 1.20). The mean value
for all participants providing a reading at this time point
was 0.967 (SD 0.166) in the left leg and 0.958 (SD 0.149)
in the right leg (Fig. 3).
There was no evidence that missing ABPI data was
not missing completely at random (MCAR) according to
Little’s MCAR test (χ2(5) = 6.93; p = 0.226).
HbA1c levels
At baseline, HbA1c data was obtained from 13 partici-
pants (range 35.0 to 75.0 mmol/l; mean 57.0 mmol/l;
SD 10.6). At 3 months, data was obtained from 6 par-
ticipants (range 42.0 to 70.0 mmol/l; mean 55.5 mmol/
l; SD 10.7). At 6 months, data was obtained from 9 par-
ticipants (range 45.0 to 63.0 mmol/l; mean 51.4 mmol/
l; SD 5.55). Hence a monotonic reduction in HbA1c
levels with time was apparent.
Nine participants provided data both at baseline and
at the final 6-month assessment. A paired samples t-test
found a mean reduction of 9.22 mmol/l (SD 7.56). A
95% confidence interval for the difference between base-
line and 6-month data was given by (3.41, 15.0). The
difference was significant at the 5% significance level
(t8 = 3.66; p = 0.006). Of these 9 participants, 7 had
dietetic consultation and were referred to the exercise
referral service.
There was no evidence that missing HbA1c data was
not missing completely at random (MCAR) according to
Little’s MCAR test (χ2(5) = 8.32; p = 0.140) (Fig. 3).
Cholesterol levels
At baseline, cholesterol data was obtained from 13 par-
ticipants (range 2.20 to 5.70 mmol/l; mean 3.75 mmol/
l; SD 1.05). At 3 months, data was obtained from 5 par-
ticipants (range 2.30 to 5.10 mmol/l; mean 3.26 mmol/
l; SD 1.18). At 6 months, data was obtained from 8 par-
ticipants (range 2.40 to 4.20 mmol/l; mean 3.33 mmol/
l; SD 0.654). Hence no clear trend in HbA1c levels with
time was apparent.
Eight participants provided data both at baseline and
at the final 6-month assessment. A paired sample t-test
found a mean reduction of 0.050 mmol/l (SD 0.414). A
95% confidence interval for the difference between base-
line and 6-month data was given by (− 0.296, 0.369), the
difference was not significant at the 5% significance level
(t7 = 0.342; p = 0.743).
There was no evidence that missing cholesterol data
was not missing completely at random (MCAR) accord-
ing to Little’s MCAR test (χ2(5) = 3.14; p = 0.678) (Fig. 4).
Fig. 2 Pulse readings representing good circulation at baseline and at 6 months, with 95% confidence intervals
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Quality of life
Eighteen participants provided responses to overall
EQ-5D quality of life (VAS item) at the baseline assess-
ment (range 3.0 to 9.0; mean 5.93; SD 1.79). At the
3-month assessment, 11 participants provided responses
(range 3.80 to 9.0; mean 7.34; SD 1.36). At the 6-month
assessment, 15 participants provided responses (range
4.0 to 9.0; mean 7.10; SD 1.28).
Fifteen participants provided data both at baseline and
at the final 6-month assessment. A paired samples t-test
found a mean increase of 1.11 points (SD 1.37). A 95%
confidence interval for the difference between baseline
and 6-month data was given by (0.352, 1.88). The differ-
ence was significant at the 5% significance level (t14 = 3.13;
p = 0.007) (Fig. 5).
There was no evidence that missing overall EQ-5D
data was not missing completely at random (MCAR) ac-
cording to Little’s MCAR test (χ2(4) = 6.53; p = 0.163).
Nineteen participants provided responses to the individ-
ual item scores at the baseline, 11 at 3 months and 15 at
the 6-month assessment.
Multivariate analysis conducted on baseline data and
data collected at the final 6-month assessment revealed
a substantive effect (partial-η2 = 0.548) of time point on
the measures assessed jointly (Wilk’s Λ = 0.452; F4,11 =
3.30; p = 0.051). Follow-up univariate analyses revealed
time-related differences to be based primarily in the pain
measure (F1,14 = 12.3; p = 0.004); with other measures
not being significantly or substantively associated with
the analysis time point. The reduction in pain of 0.50
points (from 2.37 points to 1.87 points) corresponded to
a 21.1% reduction from the baseline value (Fig. 6).
Other outcomes
Eleven participants agreed to be referred onto the exer-
cise referral service situated in the same venue and 16
participants saw the dietician for nutritional advice at
baseline and had one to one or telephone follow ups at
3 months. Of the four people who were smokers, two
stopped smoking cigarettes and moved to e-cigarettes as
part of smoking cessation advice given during the study.
Seven participants had painful neuropathic symptoms at
baseline and were referred either to their GP or to the
painful neuropathy clinic for a medication review or fur-
ther management options.
Qualitative responses
Fourteen patients completed a simple patient satisfaction
questionnaire; all of whom responded that they felt they
could discuss their symptoms of PAD with the podia-
trist, they felt involved with the treatment plan, they
were satisfied with the service and they would recom-
mend this service to a friend. When asked to rate their
PAD symptoms after completing the programme; 9
respondents felt that they symptoms were better and the
remaining 5 said that they had remained the same.
Fig. 3 HbA1c levels at baseline and at 6 months, with 95% confidence intervals
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Fig. 4 Cholesterol levels at baseline and at 6 months, with 95% confidence intervals
Fig. 5 Overall EQ-5D quality of life score at baseline and at 6 months, with 95% confidence intervals
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Some comments were made on individual experiences
during the study, one participant said: “I was referred to
the exercise referral service, this has proved to be a dra-
matic change to my general wellbeing, especially the
circulation in my legs.” Another said that:
“I have felt comfortable explaining my problems to the
podiatry team and consider them to have understood
and been able to diagnose where my problem lies. The
information I have been given is a comfort and the
advice that losing weight will help is well received. The
facility and service I have found excellent with patient
and friendly staff that one can be easily with in their
company.” However another participant had more
difficulty: “Struggled to complete exercises at the gym
due to knee pain. Ok with arm, back and chest
exercises.”
Limitations
As this was a pilot study there was no control group
which gives some limitations on the internal validity of
the study. However, the consistent and substantive
improvements recorded across a wide range of outcome
measures, in conjunction with lack of evidence for con-
current changes in patient lifestyles over the course of
the study, provides evidence that the programme was
acceptable to participants and this will inform the
development of a larger study. As 7 participants had
painful neuropathic symptoms at baseline, improve-
ments in pain scores could also be associated with other
interventions such as medication that was prescribed
during the study period. Whilst a substantial proportion
of participants were current or former smokers, the level
of concurrent co-morbidities reported was not excessive;
suggesting that the apparent beneficial effect of the
programme has not been over-stated due to regression
to the mean effects; i.e. there is no evidence that partici-
pants were skewed towards the lower end of the health
spectrum to be found in the parent population, with
correspondingly greater likelihood of natural improve-
ment over time. A certain amount of attrition was ob-
served; in general this took place between baseline and
the 3-month assessment. Many patients who did not
complete a 3-month assessment returned for a 6-month
assessment. One patient died during the course of the
study.
Discussion
Though this was a small pilot study, some substantive,
and in some cases, statistically significant improvements
with respect to many measures have been observed over
the 6-month study period. The extent of intermittent
claudication in those participants with these symptoms
(as assessed by the EICQ tool), substantively decreased,
with the proportion of respondents reporting pain or
Fig. 6 EQ-5D pain scores at baseline and at 6 months, with 95% confidence intervals
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discomfort when walking also decreasing. The propor-
tion of patients providing tri-phasic Doppler sound read-
ings increased slightly within the context of a small
overall trend primarily between baseline and 3 months;
with little further change beyond 3 months until the end
of the study period. No substantive changes in ABPI
between baseline and 6 months post baseline in either
leg were revealed.
A substantive and significant reduction was recorded
in HbA1c levels but no changes were observed in chol-
esterol levels. A significant improvement was recorded
in quality of life with improvements in pain scores being
mainly responsible for the overall improvement as mea-
sured by the quality of life instrument.
Previous studies have shown that patients with PAD
have a much reduced level of physical activity which can
be attributed to the pain associated with the disease
[14]. However, if patients are persuaded to exercise or
increase their activity levels, this can help with the
symptoms and progression of the disease, and on-going
compliance can be improved [15]. A large systematic
review comparing supervised exercise with usual care
for claudication found that exercise resulted in more
functional benefits and should be advised as part of a
treatment programme for people with PAD [16]. A Ran-
domised Controlled Trial (RCT) comparing medical care
alone, medical care plus supervised exercise and medical
care plus stent revascularisation for aortoiliac PAD
found that both exercise and revascularisation resulted
in improved clinical outcomes and quality of life up to
18 months later [11]. Rather than a prescribed exercise
programme, our study referred participants who agreed
to the exercise referral service where tailored one to one
advice was given to increase activity levels. This was pro-
vided on site in a National Centre for Sports and Exer-
cise Medicine which enabled participants’ easy access to
sports facilities at reduced rates.
Similarly, access to nutritional advice was made easy
by the presence of a dietician on site and most partici-
pants were happy to discuss their diet as part of the
programme.
Of the four patients who were smokers, two changed
to e-cigarettes as part of a smoking cessation regimen.
This follows current guidance from Public Health
England [18] which advises e-cigarettes in conjunction
with smoking cessation services. This combined
approach has contributed to improved quit success
rates.
The significant and substantive associations observed
must be considered in the context of the study being
formulated as a pilot and as such not powered to detect
significant effects. Further inferences of significance may
be anticipated in a larger follow-up study. Conversely,
however, the large number of outcome measures has led
to multiple comparisons being conducted. We have not
attempted to specify a priori any outcomes as primary
outcomes or correct for inflated Type I errors which
would be appropriate in a full-scale study. Likewise, the
size of the sample precludes the consideration of
controlling factors in comparative analyses.
Conclusion
This small, feasibility study has demonstrated important
effects on health outcomes from a pilot clinical interven-
tion for patients with PAD. The context and intervention
are reported as a novel prevention-orientated treatment
that sought to improve health outcomes. The findings
suggest that a larger follow-up study would include a
number of specific outcome measures and economic
assessment to demonstrate the effect of podiatric monitor-
ing and exercise referral for this population. Further study
is needed to examine associated behaviour change factors
that result from prevention services of this kind, particu-
larly where the professional intervention is designed to
mitigate the effects of chronic wounds, revascularisation
and amputation, particularly with the diabetic population.
The study was designed to meet the strategic vision for
allied health professions to engage in specific public health
and prevention interventions in the United Kingdom.
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